US 12,331,033 B2
Inhibitors of SARM1
Jonathan Bentley, Abingdon (GB); Todd Bosanac, New Milford, CT (US); Andrew Simon Brearley, Abingdon (GB); Sophie Catherine Cooper, Abingdon (GB); Rajesh Devraj, Chesterfield, MO (US); Robert Owen Hughes, Newtown, CT (US); Richard Andrew Jarjes-Pike, Abingdon (GB); Frederic Jacques Marlin, Abingdon (GB); Shelley Anne Parrott, Abingdon (GB); and Daniel Silva, Abingdon (GB)
Assigned to Disarm Therapeutics, Inc., Indianapolis, IN (US)
Filed by Disarm Therapeutics, Inc., Indianapolis, IN (US)
Filed on Aug. 17, 2021, as Appl. No. 17/404,523.
Application 17/404,523 is a continuation of application No. PCT/US2021/012333, filed on Jan. 6, 2021.
Claims priority of provisional application 63/065,736, filed on Aug. 14, 2020.
Claims priority of provisional application 62/958,178, filed on Jan. 7, 2020.
Prior Publication US 2023/0008433 A1, Jan. 12, 2023
Int. Cl. C07D 401/14 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01); C07D 417/04 (2006.01); C07D 471/04 (2006.01); C07D 491/052 (2006.01); C07D 495/04 (2006.01)
CPC C07D 401/14 (2013.01) [C07D 401/04 (2013.01); C07D 403/04 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 471/04 (2013.01); C07D 491/052 (2013.01); C07D 495/04 (2013.01); C07B 2200/05 (2013.01)] 6 Claims
 
1. A compound which is:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.